DocGo Inc. Depreciation Expense on Reclassified Assets
DocGo Inc. (DCGO) reported Depreciation Expense on Reclassified Assets of $8.72 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationExpenseOnReclassifiedAssets · last filed 2023-05-09
- DocGo Inc. depreciation expense on reclassified assets for the quarter ending 2023-03-31 was $8.72M.
| Period end | Depreciation Expense on Reclassified Assets 3 month | Depreciation Expense on Reclassified Assets 12 month |
|---|---|---|
| 2023-03-31 | $8.72M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $7.91M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |